EFFICACY OF A FIXED DOSE OF OMALIZUMAB DURING MULTI-ALLERGEN ORAL-IMMUNOTHERAPY

被引:2
|
作者
Sindher, S.
Kumar, D.
Purington, N.
Tupa, D.
Long, A.
Cao, S.
Woch, M.
Tan, T.
Skura, S.
Garcia-Lloret, M.
Chinthrajah, S.
机构
关键词
D O I
10.1016/j.anai.2019.08.319
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P312
引用
收藏
页码:S50 / S51
页数:3
相关论文
共 50 条
  • [41] Peanut oral immunotherapy during omalizumab protection; a clinical trial on severely peanut allergic adolescents
    Brandstrom, J.
    Vetander, M.
    Lilja, G.
    Sundqvist, A.
    Kalm, F.
    Johansson, S.
    Nilsson, C.
    Nopp, A.
    ALLERGY, 2017, 72 : 65 - 66
  • [42] Alternative dosing of omalizumab as an adjunct therapy during multiallergen oral immunotherapy in food allergic patients
    Sindher, Sayantani B.
    Long, Andrew J.
    Purington, Natasha
    Kumar, Divya
    Scheiber, Alexandra
    O'Laughlin, Katherine
    Woch, Margaret
    Tan, Tiffany
    Chinthrajah, R. Sharon
    Zedeck, Stacey Skura
    Lloret, Maria I. Garcia
    Nadeau, Kari C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB245 - AB245
  • [43] Efficacy and safety of fixed-dose oral sildenafil - Reply by the author
    Montague, DK
    UROLOGY, 1999, 54 (02) : 384 - 384
  • [44] ORAL GLUCOCORTICOIDS MAY DIMINISH EFFICACY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN EXPERIMENTAL FELINE ASTHMA
    Chang, C. H.
    DeClue, A. E.
    Cohn, L. A.
    Liu, H.
    Reinero, C. R.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (03) : 821 - 821
  • [45] Oral Immunotherapy At Fixed Low Dose for Mild to Moderate Hen's Egg Allergy
    Yanagida, Noriyuki
    Minoura, Takanori
    Ebisawa, Motohiro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB84 - AB84
  • [46] Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT
    Cetin, Gulden Pacaci
    Yilmaz, Insu
    Turk, Murat
    Arslan, Bahar
    Bahcecioglu, Sakine Nazik
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 1223 - 1234
  • [47] Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy
    Kouser L.
    Kappen J.
    Walton R.P.
    Shamji M.H.
    Current Treatment Options in Allergy, 2017, 4 (1) : 43 - 53
  • [48] The Response To Sublingual Immunotherapy With Grass Pollen Extract Administered As A Single Extract Or As Part Of A Multi-Allergen Extract In Patients With Seasonal Allergic Rhinitis Caused By Grass Pollen
    Amar, S. M.
    Harbeck, R.
    Sills, M.
    O'Brien, H.
    Nelson, H. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S75 - S75
  • [49] Anaphylaxis during Peanut Oral Immunotherapy: Looking beyond dose escalation
    Blackman, Andrea C.
    Staggers, Kristen A.
    Anagnostou, Aikaterini
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 (12)
  • [50] The use of a mucoadhesive microparticulate delivery system enables allergen dose reduction with equivalent efficacy in sublingual immunotherapy
    Tourdot, S.
    Berjont, N.
    Airouche, S.
    Da Silveira, A.
    Moussu, H.
    Betbeder, D.
    Mascarell, L.
    Nony, E.
    Moingeon, P.
    ALLERGY, 2011, 66 : 135 - 135